About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey.

Learn more
Join Putnam
Insights

Contact

Alexander Busch

Partner

Alex’s practice focuses on advising clients at the intersection of transformative pharmacology, cutting edge commercial strategy, and Value, Pricing, and Access (VPA) excellence.

Alex works with global and start-up pharmaceutical and biotechnology companies on pre-launch and in-line strategy development in key global pharma markets.

Recent therapeutic area experience includes small molecule and biopharma approaches to heme and solid tumor oncology, immunological / inflammatory diseases, and extensive work in vaccine preventable diseases.

Alex joined Putnam in 2013 after receiving his Ph.D. in Experimental and Molecular Medicine from Dartmouth (focused in new drug targets to treat lung cancer) subsequent to a B.S. in Bioinformatics and Molecular Biology from Rensselaer Polytechnic Institute.

Other members.

Remco op den Kelder

Chief Executive Officer

Yoshie Onishi

Jean Sellier

Roelien Postema

Principal Market Access